Showing results (921-930 of 1,410) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|January 16, 2026
Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research modelsM Y Schmidt, A M Cuervo, K L Double, et al.NPJ Parkinson'S Disease|January 23, 2026
Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons diseaseBlake Hale, Anna Latorre, Lorenzo Rocchi, et al.NPJ Parkinson'S Disease|January 20, 2026
Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse modelEunkyung Lee, Moon-Young Park, Minkuk Park, et al.NPJ Parkinson'S Disease|January 7, 2026
Explainable SHAP- XGBoost with DAT and clinical data for freezing of gait detection in Parkinson diseaseShuxian Jin, Yumeng Qi, Yayun Yan, et al.NPJ Parkinson'S Disease|February 13, 2026
Altered cerebrovascular haemodynamics in Parkinson's disease: Insights from 4D flow MRIAshley R Deane, Daniel J Myall, Anna Pilbrow, et al.NPJ Parkinson'S Disease|February 2, 2026
Association of LRRK2 p.A419V with Parkinson's Disease in East Asians and analysis of age at onsetKai Shi Lim, Maria Teresa Periñan, Elaine Guo Yan Chew, et al.NPJ Parkinson'S Disease|February 3, 2026
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled studyHarini Sarva, Rajesh Pahwa, Jorge Hernandez-Vara, et al.NPJ Parkinson'S Disease|December 8, 2025
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson's diseaseGioia Marino, Federica Campanelli, Giuseppina Natale, et al.NPJ Parkinson'S Disease|December 13, 2025
Creatine-weighted imaging in patients with Parkinson's diseaseKexin Wang, Nirbhay Narayan Yadav, Zijiang Yang, et al.NPJ Parkinson'S Disease|December 11, 2025
Metabolomic profiles of depression in Parkinson's disease patientsYuyuan Lin, Kimberly C Paul, Dean P Jones, et al.Pageof 141